Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Mark Mcdade Insider Profile
4 Followers
Mark Mcdade, Director at Five Prime Therapeutics, holds 0.00 shares in Five Prime Therapeutics (Ticker: FPRX), holds 0.00 shares in Icosavax (Ticker: ICVX), holds 742.21K shares in Tourmaline Bio (Ticker: TRML). Most recently, Mark Mcdade ― shares of Five Prime Therapeutics on ― for an estimated value of ―.
Profitable Transactions
0 out of 2 Profitable Transactions
Average Return
-17.40%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Mark Mcdade holds in companies
Most Profitable Insider Trade
Stock:
Icosavax
(ICVX)
(ICVX)
Rating:Informative Buy
Date:Apr 05, 2022 - Apr 05, 2023
Return:-3.80%
The most profitable trade made by Mark Mcdade
Mark Mcdade's Trading History
Five Prime Therapeutics
―
―
―
$0.00
Aimmune Therapeutics
Oct 14, 2020
―
Uninformative Sell
270.48K
$0.00
Icosavax
Feb 20, 2024
―
Uninformative Sell
―
$0.00
Tourmaline Bio
Jan 31, 2024
Director
Informative Buy
3.25M
$17.63M
Journey Medical Corp
―
Director
―
$34.44K
Dermira
―
―
―
$112.50K
PDL BioPharma
―
―
―
$114.30K
Cytokinetics
―
Director
―
$0.00
List of latest transactions for each holding click on a transaction to see Mark Mcdade's performance on stock
You May Also Like
Mark Mcdade insider profile FAQ
What is the percentage of profitable transactions made by Mark Mcdade?
The percentage of profitable transactions made by Mark Mcdade is 0%.
What is the average return per transaction made by Mark Mcdade?
The average return per transaction made by Mark Mcdade is -17.40%.
What stocks does Mark Mcdade hold?
Mark Mcdade holds: FPRX, AIMT, ICVX, TRML, DERM, ~DERM, PDLI, CYTK stocks.
What was Mark Mcdade’s latest transaction?
Mark Mcdade latest transaction was an Uninformative Buy of ―.
What was Mark Mcdade's most profitable transaction?
Mark Mcdade’s most profitable transaction was an Informative Buy of ICVX stock on April 5, 2022. The return on the trade was -3.80%.
What is Mark Mcdade's role in Five Prime Therapeutics?
Mark Mcdade's role in Five Prime Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.